Quick Takeaways
- Jonathan Piazza has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $261,878.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jonathan Piazza
- Location
- Seattle, WA
- Summary
- The estimated net worth of Jonathan Piazza is at least $261,878 dollars as of 04 May 2022. Jonathan Piazza is the Chief Financial Officer of Silverback Therapeutics, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $261.9K.
- Signature
- /s/ Jeffrey C. Pepe, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jonathan Piazza and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Silverback Therapeutics, Inc. ($261,878).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jonathan Piazza
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SPRY | Silverback Therapeutics, Inc. | Chief Financial Officer | $261,878 | 02 May 2022 |
Insider Transactions Reported by Jonathan Piazza:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.